British Columbia Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.26M Buy
21,843
+1,726
+9% +$358K 0.03% 416
2026
Q1
$4.52M Sell
20,117
-5,736
-22% -$1.43M 0.03% 388
2025
Q4
$6.23M Buy
25,853
+4,781
+23% +$1.22M 0.03% 356
2025
Q3
$5.77M Sell
21,072
-2,039
-9% -$557K 0.03% 337
2025
Q2
$5.96M Sell
23,111
-4,967
-18% -$1.18M 0.03% 335
2025
Q1
$6.29M Sell
28,078
-24
-0.1% -$5.6K 0.04% 345
2024
Q4
$6.43M Buy
28,102
+3,593
+15% +$865K 0.04% 350
2024
Q3
$5.98M Sell
24,509
-3,662
-13% -$818K 0.04% 344
2024
Q2
$5.39M Buy
28,171
+10,609
+60% +$2.15M 0.03% 367
2024
Q1
$3.48M Buy
17,562
+624
+4% +$114K 0.02% 416
2023
Q4
$2.91M Buy
16,938
+3,573
+27% +$549K 0.02% 426
2023
Q3
$1.98M Buy
13,365
+119
+0.9% +$21.5K 0.02% 448
2023
Q2
$2.89M Buy
13,246
+203
+2% +$45.2K 0.03% 386
2023
Q1
$2.86M Buy
13,043
+72
+0.6% +$15.6K 0.03% 374
2022
Q4
$2.7M Sell
12,971
-1,499
-10% -$329K 0.03% 376
2022
Q3
$3.16M Sell
14,470
-2,555
-15% -$582K 0.04% 350
2022
Q2
$3.57M Sell
17,025
-5,471
-24% -$1.16M 0.03% 361
2022
Q1
$5.46M Sell
22,496
-3,097
-12% -$749K 0.03% 367
2021
Q4
$6.67M Sell
25,593
-1,280
-5% -$332K 0.04% 370
2021
Q3
$7.08M Sell
26,873
-24
-0.1% -$6.56K 0.04% 351
2021
Q2
$6.63M Buy
26,897
+3,126
+13% +$657K 0.04% 369
2021
Q1
$4.61M Sell
23,771
-732
-3% -$147K 0.03% 410
2020
Q4
$5.21M Sell
24,503
-588
-2% -$117K 0.04% 369
2020
Q3
$4.3M Buy
25,091
+1,916
+8% +$354K 0.04% 378
2020
Q2
$4.45M Buy
23,175
+7,446
+47% +$1.22M 0.04% 325
2020
Q1
$2.32M Sell
15,729
-18,126
-54% -$2.89M 0.04% 326
2019
Q4
$5.25M Buy
33,855
+58
+0.2% +$8.36K 0.04% 355
2019
Q3
$4.57M Sell
33,797
-6,701
-17% -$878K 0.04% 395
2019
Q2
$4.94M Sell
40,498
-709
-2% -$78.5K 0.04% 443
2019
Q1
$4.28M Sell
41,207
-35,917
-47% -$3.71M 0.04% 470
2018
Q4
$8.78M Sell
77,124
-22,034
-22% -$2.36M 0.08% 256
2018
Q3
$11.4M Sell
99,158
-17,344
-15% -$1.9M 0.12% 188
2018
Q2
$12.1M Buy
116,502
+28,769
+33% +$2.91M 0.11% 226
2018
Q1
$8.64M Buy
87,733
+14,209
+19% +$1.34M 0.07% 339
2017
Q4
$6.23M Hold
73,524
0.04% 443
2017
Q3
$5.66M Sell
73,524
-12,193
-14% -$933K 0.04% 438
2017
Q2
$6.67M Buy
85,717
+17,000
+25% +$1.22M 0.05% 402
2017
Q1
$4.95M Sell
68,717
-22,754
-25% -$1.57M 0.04% 480
2016
Q4
$5.68M Buy
91,471
+10,235
+13% +$627K 0.05% 424
2016
Q3
$5.26M Sell
81,236
-47,799
-37% -$3.18M 0.05% 410
2016
Q2
$8.16M Buy
129,035
+7,753
+6% +$457K 0.07% 304
2016
Q1
$7.01M Buy
121,282
+61,730
+104% +$3.49M 0.07% 339
2015
Q4
$3.2M Buy
59,552
+31,572
+113% +$1.78M 0.03% 554
2015
Q3
$1.43M Sell
27,980
-10,600
-27% -$571K 0.01% 595
2015
Q2
$2.17M Hold
38,580
0.02% 553
2015
Q1
$2.77M Sell
38,580
-7,695
-17% -$500K 0.03% 514
2014
Q4
$2.59M Buy
46,275
+17,134
+59% +$895K 0.02% 530
2014
Q3
$1.44M Buy
29,141
+13,212
+83% +$673K 0.01% 583
2014
Q2
$806K Buy
15,929
+7,500
+89% +$372K 0.01% 640
2014
Q1
$377K Hold
8,429
﹤0.01% 715
2013
Q4
$397K Sell
8,429
-2,734
-24% -$138K ﹤0.01% 714
2013
Q3
$590K Sell
11,163
-24,506
-69% -$1.19M 0.01% 653
2013
Q2
$1.61M Buy
+35,669
New +$1.69M 0.01% 571

Other funds holding RMD

British Columbia Investment Management's RMD Position: Q2 2026 in Review

British Columbia Investment Management increased its ResMed (RMD) stake by 8.6% in Q2 2026, buying an estimated $358K and bringing the position to 21,843 shares worth $4.26M. The position accounts for 0.03% of the portfolio, ranked #416.

British Columbia Investment Management first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.1M in Q2 2018. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • British Columbia Investment Management held 21,843 shares of ResMed worth $4.26M as of Q2 2026.
  • British Columbia Investment Management bought 1,726 ResMed shares in Q2 2026, an estimated $358K.
  • ResMed made up 0.03% of British Columbia Investment Management's portfolio in Q2 2026, its #416 holding.
  • British Columbia Investment Management first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • British Columbia Investment Management's ResMed position peaked at $12.1M in Q2 2018.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.